Eledon Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Eledon Pharmaceuticals

30/03/2023 22:02

* Eledon Pharmaceuticals Inc  ELDN.OQ  reported a quarterly
adjusted loss of 69 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 70 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Eledon Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $4.12​.
    * The mean earnings estimate of analysts had fallen by
about 14.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Eledon Pharmaceuticals Inc shares had risen by 3.9% this
quarter.
    * The company reported a quarterly loss of $58.38 million.
    * Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $10.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 30 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.70          -0.69          Beat
 Sep. 30 2022      -0.68          -0.73          Missed
 Jun. 30 2022      -0.70          -0.65          Beat
 Mar. 31 2022      -0.68          -0.69          Missed